NCT04167085View on ClinicalTrials.gov

NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
Epistaxis
Interventions
DRUG

Doxycycline

Doxycycline, 100 mg twice a day for 2 months

OTHER

Placebo

Matching placebo, twice a day for 2 months

Trial Locations (1)

90095

100 UCLA Medical Plaza, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT04167085 - NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial | Biotech Hunter | Biotech Hunter